Pfizer Seeks US Approval of Covid Vaccine for Children under 5

Pfizer and BioNTech said on February 1, 2022 that they began submitting a formal request to US health regulators for emergency use of their Covid vaccine for children aged over six months and under five years. JOEL SAGET AFP/File

Pfizer and BioNTech said Tuesday they are seeking emergency authorization from US health regulators for use of their Covid vaccine for children aged over six months and under five years.

If the Food and Drug Administration (FDA) authorizes the two-shot regimen, it will become the first Covid vaccine available to this age group in the United States, AFP reported.